Company Description

Xdemics is developing the High-Density Cell Respiration (HDCR™) platform to overcome the oxygen delivery and shear stress limitations of conventional cell culture systems, enabling direct control of pericellular oxygen at any setpoint and achieving 10-100X higher cell densities with improved functional activity and quality.